197 related articles for article (PubMed ID: 15002709)
1. [Percutaneous closure of patent foramen ovale: preliminary experience with the PFO Star].
Stauffer JC; Serra M; Juillard JM; Seydoux C; Perret F; Owlya R; Savcic M; Beuret P; Goy JJ
Arch Mal Coeur Vaiss; 2004 Jan; 97(1):37-41. PubMed ID: 15002709
[TBL] [Abstract][Full Text] [Related]
2. Interventional closure with Amplatzer PFO occluder of patent foramen ovale in patients with paradoxical cerebral embolism.
Chatterjee T; Petzsch M; Ince H; Rehders TC; Körber T; Weber F; Schneider H; Auf der Maur C; Nienaber CA
J Interv Cardiol; 2005 Jun; 18(3):173-9. PubMed ID: 15966921
[TBL] [Abstract][Full Text] [Related]
3. New onset atrial fibrillation after patent foramen ovale closure.
Staubach S; Steinberg DH; Zimmermann W; Wawra N; Wilson N; Wunderlich N; Sievert H
Catheter Cardiovasc Interv; 2009 Nov; 74(6):889-95. PubMed ID: 19626689
[TBL] [Abstract][Full Text] [Related]
4. [Percutaneous closure of patent foramen ovale with amplatzer device. Report of two cases].
Munayer Calderón JE; Maza Juárez G; Carpio JC; Aldana Pérez T; Lázaro Castillo JL; San Luis Miranda R; Ramírez H; Amaya A; Pineda JL
Arch Cardiol Mex; 2005; 75(3):306-9. PubMed ID: 16294819
[TBL] [Abstract][Full Text] [Related]
5. Patent foramen ovale closure with the Intrasept occluder: Complete 6-56 months follow-up of 247 patients after presumed paradoxical embolism.
Spies C; Timmermanns I; Reissmann U; van Essen J; Schräder R
Catheter Cardiovasc Interv; 2008 Feb; 71(3):390-5. PubMed ID: 18288745
[TBL] [Abstract][Full Text] [Related]
6. Feasibility of patent foramen ovale closure with no-device left behind: first-in-man percutaneous suture closure.
Ruiz CE; Kipshidze N; Chiam PT; Gogorishvili I
Catheter Cardiovasc Interv; 2008 Jun; 71(7):921-6. PubMed ID: 18412251
[TBL] [Abstract][Full Text] [Related]
7. Transcatheter closure versus medical therapy of patent foramen ovale and cryptogenic stroke.
Thanopoulos BV; Dardas PD; Karanasios E; Mezilis N
Catheter Cardiovasc Interv; 2006 Nov; 68(5):741-6. PubMed ID: 17039525
[TBL] [Abstract][Full Text] [Related]
8. Late cardiac perforation after transcatheter closure of patent foramen ovale.
Cecconi M; Quarti A; Bianchini F; Bucari S; Costantini C; Giovagnoni A; Perna GP
Ann Thorac Surg; 2006 Jun; 81(6):e29-30. PubMed ID: 16731110
[TBL] [Abstract][Full Text] [Related]
9. Percutaneous closure of atrial septal defects: a decade of experience at a reference center.
Fiarresga A; De Sousa L; Martins JD; Ramos R; Paramés F; Freitas I; Oliveira JA; Trigo C; Agapito A; Ferreira RC; Pinto F
Rev Port Cardiol; 2010 May; 29(5):767-80. PubMed ID: 20866006
[TBL] [Abstract][Full Text] [Related]
10. Comparison of results of percutaneous closure of patent foramen ovale for paradoxical embolism in patients with versus without thrombophilia.
Giardini A; Donti A; Formigari R; Bronzetti G; Prandstraller D; Bonvicini M; Palareti G; Guidetti D; Gaddi O; Picchio FM
Am J Cardiol; 2004 Oct; 94(8):1012-6. PubMed ID: 15476614
[TBL] [Abstract][Full Text] [Related]
11. Percutaneous closure of patent foramen ovale with a bioabsorbable occluder device: single-centre experience.
Ussia GP; Cammalleri V; Mulè M; Scarabelli M; Barbanti M; Scardaci F; Mangiafico S; Immè S; Capodanno D; Tamburino C
Catheter Cardiovasc Interv; 2009 Oct; 74(4):607-14. PubMed ID: 19360875
[TBL] [Abstract][Full Text] [Related]
12. Resolution of migraine by transcatheter patent foramen ovale closure with Premere Occlusion System in a preliminary series of patients with previous cerebral ischemia.
Rigatelli G; Cardaioli P; Braggion G; Giordan M; Fabio D; Aggio S; Roncon L; Chinaglia M
Catheter Cardiovasc Interv; 2007 Sep; 70(3):429-33. PubMed ID: 17722021
[TBL] [Abstract][Full Text] [Related]
13. Percutaneous closure of patent foramen ovale and atrial septal defect in adults: the impact of clinical variables and hospital procedure volume on in-hospital adverse events.
Opotowsky AR; Landzberg MJ; Kimmel SE; Webb GD
Am Heart J; 2009 May; 157(5):867-74. PubMed ID: 19376313
[TBL] [Abstract][Full Text] [Related]
14. Transcatheter closure of patent foramen ovale in older adults.
Kiblawi FM; Sommer RJ; Levchuck SG
Catheter Cardiovasc Interv; 2006 Jul; 68(1):136-42; discussion 143-4. PubMed ID: 16755591
[TBL] [Abstract][Full Text] [Related]
15. Transcatheter closure of patent foramen ovale, atrial septal defect and left atrial appendage.
Majunke N; Wallenborn J; Wunderlich N; Sievert H
Minerva Cardioangiol; 2009 Feb; 57(1):103-15. PubMed ID: 19202522
[TBL] [Abstract][Full Text] [Related]
16. Percutaneous closure of patent foramen ovale in patients with presumed paradoxical embolism: periprocedural results and midterm risk of recurrent neurologic events.
Balbi M; Casalino L; Gnecco G; Bezante GP; Pongiglione G; Marasini M; Del Sette M; Barsotti A
Am Heart J; 2008 Aug; 156(2):356-60. PubMed ID: 18657668
[TBL] [Abstract][Full Text] [Related]
17. Cardiac perforation during patent foramen ovale closure sealed with an amplatzer PFO occluder.
Chiam PT; Schneider LM; Ruiz CE
J Invasive Cardiol; 2008 Dec; 20(12):665-8. PubMed ID: 19057033
[TBL] [Abstract][Full Text] [Related]
18. Clinical and brain magnetic resonance imaging follow-up after percutaneous closure of patent foramen ovale in patients with cryptogenic stroke.
Vigna C; Inchingolo V; Giannatempo G; Pacilli MA; Di Viesti P; Fusilli S; Amico CM; Santoro T; Lanna P; Fanelli R; Simone P; Loperfido F
Am J Cardiol; 2008 Apr; 101(7):1051-5. PubMed ID: 18359330
[TBL] [Abstract][Full Text] [Related]
19. [Percutaneous closure of patent foramen ovale, as secondary prevention of cryptogenic cerebral event].
Temesvári A; Bálint OH; Liptai C; Kancz S; Németh B; Szatmári A
Orv Hetil; 2006 Oct; 147(42):2035-9. PubMed ID: 17165604
[TBL] [Abstract][Full Text] [Related]
20. Percutaneous transcatheter closure of patent foramen ovale with the Amplatzer Cribriform septal occluder.
Silvestry FE; Naseer N; Wiegers SE; Hirshfeld JW; Herrmann HC
Catheter Cardiovasc Interv; 2008 Feb; 71(3):383-7. PubMed ID: 18288733
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]